BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24787227)

  • 21. The presence of methylation of the p16INK4A gene and human papillomavirus in high-grade cervical squamous intraepithelial lesions.
    Furtado YL; Almeida G; Lattario F; Silva KS; Maldonado P; Silveira FA; do Val IC; Fonseca R; Carvalho Mda G
    Diagn Mol Pathol; 2010 Mar; 19(1):15-9. PubMed ID: 20186007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aberrant promoter methylation as biomarker for molecular cytological diagnosis of lung cancer].
    Grote HJ
    Verh Dtsch Ges Pathol; 2006; 90():216-26. PubMed ID: 17867600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.
    Shih YL; Hsieh CB; Yan MD; Tsao CM; Hsieh TY; Liu CH; Lin YW
    J Gastroenterol Hepatol; 2013 Mar; 28(3):551-9. PubMed ID: 23215838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
    Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
    Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
    Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
    Hiraki M; Kitajima Y; Koga Y; Tanaka T; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
    Ann Surg Oncol; 2011 Oct; 18(10):3013-9. PubMed ID: 21409489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
    Sugita H; Iida S; Inokuchi M; Kato K; Ishiguro M; Ishikawa T; Takagi Y; Enjoji M; Yamada H; Uetake H; Kojima K; Sugihara K
    Oncol Rep; 2011 Feb; 25(2):513-8. PubMed ID: 21152877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
    Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
    J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study.
    Schmiemann V; Böcking A; Kazimirek M; Onofre AS; Gabbert HE; Kappes R; Gerharz CD; Grote HJ
    Clin Cancer Res; 2005 Nov; 11(21):7728-34. PubMed ID: 16278393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of frequent differentially methylated region in sporadic bladder cancers.
    Hasegawa R; Fujiwara K; Obinata D; Kawashima H; Shinojima Y; Igarashi J; Wang X; Ghosh S; Nagase H; Takahashi S
    Urol Int; 2015; 94(4):479-84. PubMed ID: 25227574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function.
    Deutschmeyer V; Breuer J; Walesch SK; Sokol AM; Graumann J; Bartkuhn M; Boettger T; Rossbach O; Richter AM
    Clin Epigenetics; 2019 Dec; 11(1):182. PubMed ID: 31801617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.
    Zhang W; Cao H; Yang J; Zhao J; Liang Z; Kang X; Wang R
    BMC Cancer; 2022 Jun; 22(1):636. PubMed ID: 35681118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ZAR1 protein in cancer; from epigenetic silencing to functional characterisation and epigenetic therapy of tumour suppressors.
    Deutschmeyer VE; Richter AM
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188417. PubMed ID: 32828887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and expression analysis of zygote arrest 1 (Zar1) in New Zealand white rabbits.
    Wang D; Xie SY; Zhang W; Sun CX; Huang T; Wang AS; Han XL; Sun GR; Li M
    J Genet; 2017 Mar; 96(1):3-8. PubMed ID: 28360383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.